Anticoagulation Timing in Cardioembolic Stroke and Recurrent Event Risk.

Authors

Shadi Yaghi
Tushar Trivedi
Nils Henninger
James Giles
Angela Liu
Muhammad Nagy
Ashutosh Kaushal
Idrees Azher
Brian Mac Grory
Hiba Fakhri
Kiersten Brown Espaillat
Syed Daniyal Asad
Hemanth Pasupuleti
Heather Martin
Jose Tan
Manivannan Veerasamy
Ava L Liberman
Charles Esenwa
Natalie Cheng
Khadean Moncrieffe
Iman Moeini-Naghani, George Washington University
Mithilesh Siddu, George Washington University
Erica Scher
Christopher R. Leon Guerrero, George Washington University
Muhib Khan
Amre Nouh
Eva Mistry
Salah Keyrouz
Karen Furie

Document Type

Journal Article

Publication Date

7-12-2020

Journal

Annals of Neurology

DOI

10.1002/ana.25844

Comments

Online ahead of print

APA Citation

Yaghi, S., Trivedi, T., Henninger, N., Giles, J., Liu, A., Nagy, M., Kaushal, A., Azher, I., Grory, B., Fakhri, H., Espaillat, K., Asad, S., Pasupuleti, H., Martin, H., Tan, J., Veerasamy, M., Liberman, A., Esenwa, C., Cheng, N., Moncrieffe, K., Moeini-Naghani, I., Siddu, M., Scher, E., Leon Guerrero, C. R., Khan, M., Nouh, A., Mistry, E., Keyrouz, S., & Furie, K. (2020). Anticoagulation Timing in Cardioembolic Stroke and Recurrent Event Risk.. Annals of Neurology, (). http://dx.doi.org/10.1002/ana.25844

Peer Reviewed

1